<DOC>
	<DOC>NCT00670644</DOC>
	<brief_summary>RATIONALE: Identifying why patients don't do self care for lymphedema may help doctors plan better at-home self-care treatment. PURPOSE: This research study is looking at self-care practices for lymphedema in patients with breast cancer.</brief_summary>
	<brief_title>Self-Care for Lymphedema in Patients With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES: Primary - To systematically identify and describe the barriers to completing recommended at home self-care of lymphedema in patients with breast cancer. - To identify patient recalled instructions as to at home self-care practices for lymphedema as told to them by healthcare professionals and others. - To identify the current at home self-care practices of breast cancer survivors with treatment treated lymphedema. Secondary - To examine the relationship between at home self-care activities and symptoms in breast cancer survivors with lymphedema. - To examine the relationship between at home self-care activities and quality of life in breast cancer survivors with lymphedema. - To identify patient-perceived benefits to at home self-care. OUTLINE: Patients complete questionnaires about their breast cancer diagnosis and treatment history, lymphedema history and problems, and years of education and income. Patients also complete surveys about home self-care practices for lymphedema and any benefits, burdens, or barriers of at home care.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: History of breast cancer Lymphedema in one or both arms that occurred during or after breast cancer treatment Must have received prior lymphedema treatment by a healthcare professional Patients with selfreported arm swelling subsequent to breast cancer treatment that has not been treated by a healthcare professional are not eligible Hormone receptor status not specified PATIENT CHARACTERISTICS: Menopausal status not specified English speaking PRIOR CONCURRENT THERAPY: See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>male breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>